ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
MedKoo Cat#: 555334
Name: ETX0282
CAS#: 2209871-83-8
Chemical Formula: C13H18FN3O5
Exact Mass: 315.1230
Molecular Weight: 315.30
Elemental Analysis: C, 49.52; H, 5.75; F, 6.03; N, 13.33; O, 25.37
The following data is based on the product molecular weight 315.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
